neuroClues
Our mission is to empower clinicians with Biomarkers allowing them to identify Neurological Disorders (Parkinson's Disease, Alzheimer's Disease and Multiple Sclerosis) years before visible symptoms.
Louvain-la-Neuve, Belgiumwww.neuroclues.com ↗
Total raised
€15M
€14,999,998
Funding rounds
2
Investors
6
distinct backers
Active since
2024-04
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 12% (2+ rounds)
- ▼ Young (<3y)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-07 | Series A | €10.0M | EIC Fund,Existing investors,Olivier Legrain,TeamPact Ventures,White Fund | View deal → |
| 2024-04-30 | Seed | €5.0M | the European Commission’s EIC Accelerator program,White Fund | View deal → |
Investors
6Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Kpler€1.0BBelgium · Software